Pharmacist Information Hub

How to file an SAS-C notification

  1. Log in to the SAS and AP Online System
  2. Select ‘SAS Dashboard’ from the top menu
  3. Click the ‘New SAS Application’ button
  4. Enter the information as detailed below

Best viewed on desktop

Prescriber detailsPrescriber
  • Prescriber’s AHPRA registration number
Submitter
  • Business / Practice name;
  • Email address;
  • Physical address
Click ‘Save and next
Product selectionTherapeutic good type
  • Select ‘Medicine
Active ingredients
  • Search for and select ‘Nicotine
Dosage form
  • Select ‘Solid/liquid
Indication

If filing on behalf of prescriber:

  • Smoking cessation or management of nicotine dependence in patients aged 16 and over (M164)

If filing on supply of S3 vapes:

  • Smoking cessation or management of nicotine dependence in patients 18 and over, concentration 20mg/mL or less (M165)
Click ‘Save and next
Product detailsTherapeutic vaping product type

Select one of the following:

  • Nicotine vaping product; or
  • Zero-nicotine vaping product; or
  • Combination of the above
Expected duration of treatment

If filing on behalf of prescriber:

  • Quantity of vaping product prescribed + Number of repeats

If filing on supply of S3 vapes:

  • Quantity of S3 vapes supplied
Intended date of supply
  • Date of dispensing
Click ‘Save and next
PatientThree (3) patient identifiers
  • Patient initials;
  • Gender; and
  • Date of birth
Diagnosis

Either:

  • Smoking cessation’ (for dependent smoker); or
  • Management of nicotine dependence’ (for dependent vaper)
I have considered approved and available treatments for this patient

If filing on behalf of prescriber, ask patient if alternative options were discussed.

  • If so, select ‘Yes

If filing on supply of S3 vapes:

  • Select ‘Yes
Supporting information
  • Select ‘No
Click ‘Save and next
SubmissionPrivacy statement and consent
  • Select ‘Yes
Click ‘Submit
SAS submission completedDownload a copy of the receipt
  • Retain a copy of the SAS-C notification receipt for your records
  • The SAS-C notification number appears on the top right-hand side of the receipt
  • If filing on behalf of prescriber, forward a copy of the SAS-C notification receipt to the prescribing practitioner
Supplying and Dispensing Therapeutic Vapes
Nicovape Q products are TGA notified therapeutic vaping goods indicated for smoking cessation or the management of nicotine dependence. TGA Notification ID numbers: VG-2024-NTF-00234, VG-2024-NTF-00241, VG-2024-NTF-00240, VG-2024-NTF-00235, VG-2024-NTF-00242, VG-2024-NTF-00239, VG-2024-NTF-00237, VG-2024-NTF-00243, VG-2024-NTF-00238, VG-2024-NTF-00236.

© 2024 Liber Pharmaceuticals Ltd. All content

iNRT Healthcare is operated by Liber Pharmaceuticals for the purpose of furthering healthcare education regarding Nicotine Vaping Products (NVPs) within the Australian medical framework. Liber has no affiliation with the tobacco industry, their affiliates, or any organisations or individuals engaged in lobbying on their behalf.

This site is intended for use only by Australian-registered healthcare professionals with an interest in smoking cessation. It is not intended for use by consumers.